Antibiofilm effect of warfarin on biofilm formation of Escherichia coli promoted by antimicrobial treatment

Journal of Global Antimicrobial Resistance

Volumn 7, Issue , 2016, Pages 102-105

  Ojima, Yoshihiro ^a   Nunogami, Shota ^b   Taya, Masahito ^b  

^a Osaka Prefecture University   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Biofilm; Escherichia coli; Lactoferrin; Warfarin

Indexed keywords

AMPICILLIN; LACTOFERRIN; POLYMYXIN B; WARFARIN; ANTIINFECTIVE AGENT;

ANTIBIOFILM EFFECT; ARTICLE; BACTERIAL STRAIN; BIOFILM; CELL CULTURE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ESCHERICHIA COLI; MICROTITER PLATE ASSAY; NONHUMAN; PRIORITY JOURNAL; ESCHERICHIA COLI INFECTION; MICROBIAL SENSITIVITY TEST;

AMPICILLIN; ANTI-BACTERIAL AGENTS; BIOFILMS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; LACTOFERRIN; MICROBIAL SENSITIVITY TESTS; WARFARIN;

EID: 84989211065     PISSN: 22137165     EISSN: 22137173     Source Type: Journal    
DOI: 10.1016/j.jgar.2016.08.003     Document Type: Article

References (18)

1. [1] Stoodley, P., Sauer, K., Davies, D.G., Costerton, J.W., Biofilms as complex differentiated communities. Annu Rev Microbiol 56 (2002), 187–209.
2. [2] Brunner, M., Hollenstein, U., Delacher, S., Jager, D., Schmid, R., Lackner, E., et al. Distribution and antimicrobial activity of ciprofloxacin in human soft tissues. Antimicrob Agents Chemother 43 (1999), 1307–1309.
3. [3] McColm, A.A., Ryan, D.M., Penetration of β-lactam antibiotics into cardiac vegetations, aorta and heart muscle in experimental Staphylococcus aureus endocarditis: comparison of ceftazidime, cefuroxime and methicillin. J Antimicrob Chemother 16 (1985), 349–358.
4. [4] Ahmed, N.A., Petersen, F.C., Scheie, A.A., AI-2/LuxS is involved in increased biofilm formation by Streptococcus intermedius in the presence of antibiotics. Antimicrob Agents Chemother 53 (2009), 4258–4263.
5. [5] Bagge, N., Schuster, M., Hentzer, M., Ciofu, O., Givskov, M., Greenberg, E.P., et al. Pseudomonas aeruginosa biofilms exposed to imipenem exhibit changes in global gene expression and β-lactamase and alginate production. Antimicrob Agents Chemother 48 (2004), 1175–1187.
6. [6] Rachid, S., Ohlsen, K., Witte, W., Hacker, J., Ziebuhr, W., Effect of subinhibitory antibiotic concentrations on polysaccharide intercellular adhesin expression in biofilm-forming Staphylococcus epidermidis. Antimicrob Agents Chemother 44 (2000), 3357–3363.
7. [7] Hoffman, L.R., D'Argenio, D.A., MacCoss, M.J., Zhang, Z., Jones, R.A., Miller, S.I., Aminoglycoside antibiotics induce bacterial biofilm formation. Nature 436 (2005), 1171–1175.
8. [8] Costa, J.C., Espeschit Ide, F., Pieri, F.A., Benjamin Ldos, A., Moreira, M.A., Increased production of biofilms by Escherichia coli in the presence of enrofloxacin. Vet Microbiol 160 (2012), 488–490.
9. [9] Farnaud, S., Evans, R.W., Lactoferrin—a multifunctional protein with antimicrobial properties. Mol Immunol 40 (2003), 395–405.
10. [10] Ochoa, T.J., Cleary, T.G., Effect of lactoferrin on enteric pathogens. Biochimie 91 (2009), 30–34.
11. [11] Appelmelk, B.J., An, Y.Q., Geerts, M., Thijs, B.G., de Boer, H.A., MacLaren, D.M., et al. Lactoferrin is a lipid A-binding protein. Infect Immun 62 (1994), 2628–2632.
12. [12] Sheffield, C.L., Crippen, T.L., Poole, T.L., Beier, R.C., Destruction of single-species biofilms of Escherichia coli or Klebsiella pneumoniae subsp. pneumoniae by dextranase, lactoferrin, and lysozyme. Int Microbiol 15 (2012), 185–189.
13. [13] Ammons, M.C., Copie, V., Mini-review: lactoferrin: a bioinspired, anti-biofilm therapeutic. Biofouling 29 (2013), 443–455.
14. [14] Wysowski, D.K., Nourjah, P., Swartz, L., Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action. Arch Intern Med 167 (2007), 1414–1419.
15. [15] Baba, T., Ara, T., Hasegawa, M., Takai, Y., Okumura, Y., Baba, M., et al. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol, 2, 2006 2006.0008.
16. [16] Nguyen, M.H., Ojima, Y., Kawata, T., Taya, M., Alternation in colonization behaviors of Escherichia coli cells with rpoS or yggE deficiency on solid surfaces. Biotechnol Bioeng 110 (2013), 1050–1056.
17. [17] Saraf, K., Morris, P., Garg, P., Sheridan, P., Storey, R., Non-vitamin K antagonist oral anticoagulants (NOACs): clinical evidence and therapeutic considerations. Postgrad Med J 90 (2014), 520–528.
18. [18] Berditsch, M., Jager, T., Strempel, N., Schwartz, T., Overhage, J., Ulrich, A.S., Synergistic effect of membrane-active peptides polymyxin B and gramicidin S on multidrug-resistant strains and biofilms of Pseudomonas aeruginosa. Antimicrob Agents Chemother 59 (2015), 5288–5296.